Supplementary Data. The Seller will provide the Buyer with data supplementary to the Provisioning Data, comprising local manufacture tables, ground support equipment, specific-to-type tools and a pool item candidate list.
Supplementary Data. The Seller will provide the Buyer with Local Manufacture Tables (X-File), as part of the Illustrated Parts Catalog (Additional Cross-Reference Tables), which will be a part of the Initial Provisioning Data Package.
Supplementary Data. The Seller shall provide the Buyer with supplementary data to the Initial Provisioning Data, including Local Manufacture Tables (X-File) and Ground Support Equipment and Specific (To-Type) Tools (W-File) in accordance with SPEC 2000, Chapter 1.
Supplementary Data. AirPlus may provide supplementary information about transactions if Customer requested the provision of such on the Account application. AirPlus cannot provide such supplementary data without the cooperation of Customer’s travel agent(s), and Customer will need to make arrangements with its travel agent(s) for the provision of the services necessary for AirPlus to provide the supplementary data. However, Customer shall not be entitled to withhold payment from AirPlus on the grounds that any supplementary data does not appear on Customer’s statement or appears to be incorrect.
Supplementary Data. The Seller will provide the Buyer with Local Manufacture Tables (X-File), and Ground Support Equipment and Specific to-type Tools (W-File) and a Pool Item Candidate List (Y-File) as a part of the Initial Provisioning Data package.
Supplementary Data. The Seller shall provide the Buyer with data supplementary to the Provisioning Data, comprising local manufacture tables, ground support equipment, specific-to-type tools and a pool item candidate list. The list of spare parts required for the installation of all airframe LRUs will be provided by the Seller to the Buyer during the Initial Provisioning Conference
Supplementary Data. Any Supplementary Data required for the Design can be obtained from the below mentioned Data. ❖ Design Speed 65 kmph ❖ Chemical Contents of Subsoil and Subsoil Work • Sulphate Content in Soil • Sulphate Content in Water Contractor shall verify the Conditions • Chloride Content in Soil • Chloride Content in Water ❖ Temperature Range ± 170C
Supplementary Data. Genotoxicity Aside the NANoREG project, the genotoxicity of NM103 and NM104 was tested in vitro on Caco2 cells for concentrations up to 256 μg/ml during a bilateral ANR/DFG project between France and Germany (SolNanoTox) with both, the comet assay modified with FpG enzyme for detection of oxidized bases and the micronucleus assay. The outcomes are presented in table 1. TEST NM103 NM104 COMET ASSAY Negative Negative COMET ASSAY +FpG Negative Negative MICRONUCLEUS ASSAY Negative* Negative* *due to the interference with the assay (NPs masking the cytoplasm and the potential presence of micronuclei) it cannot be conclude that no induction of micronuclei occurred at the highest concentrations tested. Table 1: Response of differentiated Caco2 cells on exposure towards NM103 and 104 for 24h
Supplementary Data. Sup. Text S1 Sup. Text S2 Opensmile Audio features Opensmile Feature selecuon vs child-completed diary cards vs an objecuve method. Eur Respir J. 1998;11(2):щ62-6. 15 Kruizinga MD, Xxxxxxxx FE, Xxxxxxxxxxx V, Xxxx XX, Xxxxxxxxxx XX, Xxxxxxxxxx XX, et al. Development of Novel,Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validauon. Pharmacol Rev. 2020;72 (щ)(October):899-909. 16 Kruizinga MD, Stuurman FE, Xxxxxxxxxx XX, Xxxxx AF. The Future of Clinical Trial Design: The Transiuon from Hard Sup. Figure S2a Example of distribuuon plots of each feature used during the feature selecuon process Sup. Figure S3 Feature importance plot Chapter 5 Technical validity and usability of a novel smartphone connected spirometry device for pediatric patients with asthma and cystic fibrosis Pediatr Pulmonol.2020 Sep;55(9):2463-2470.doi:10.1002/ppul.24932.Epub 2020 Jul 8 MD Xxxxxxxxx,1,2,3,4 E Essers,1,2 FE Stuurman,1,4 A Zhuparris,1 N van Eik,2 XX Xxxxxxxx,3 I Xxxxxxxxx,2 AJ Sprij,2 M Nuijsink,2 XX Xxxxx,1,4 GJA Driessen2 *Bothauthors contributed equally
Supplementary Data. Sup. Figure S1 Median (iqR) compliance to study tasks by age Sup. Figure S2 Decrease in compliance over ume Sup. Table S3 Tolerability quesuonnaire Sup. Table S4 Model Coefficients of physical acuvity-related candidate endpoints. Sup. Table S5 Model coefficients of heart rate parameters Sup. Table S6 Model coefficients of accelerometer-derived sleep parameters Sup. Figure S7 Sleep durauon by day of the week Sup. Figure S8 Blood pressure measurements per age year Sup. Figure S9 Temperature measurements per age year Sup. Data S10 Complete dataset generated during this study Sup. Table S11 Dataset legend Sup. File S12 R code used during analysis Sup. File S13 End-of-study quesuonnaire referenCes 1 Pasquali SK, Lam WK, Chiswell K, Kemper AR, Li JS. Status of the pediatric clinical trials enterprise: An analysis of the us ClinicalTrials.gov registry. Pediatrics. 2012;130. doi:10.15щ2/ peds.2011-3565 2 Roser M, Ritchie H. Burden of Disease. 2016 p. Published online at OurWorldInData.org. Retrieved.
